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To test the hypothesis that delayed onset
muscular soreness (DOMS) following intense
eccentric muscle contraction could be due to
increased production of prostaglandin E2 (PGE2),
ten healthy male subjects were studied. Using a
double-blind randomized crossover design, each
subject performed two isokinetic tests separated
by a period of at least 6 weeks: once with
placebo, and once with piroxicam (Feldene(R)).
They were given one capsule containing either
placebo or piroxicam (20 mg) per day for 6 days
with initial doses given starting 3 days prior to
isokinetic testing. Exercise consisted of eight
stages of five maximal contractions of the knee
extensor and flexor muscle groups of both legs
separated by 1 min rest phases, on a Kin Trex
device at 60/s angular velocity. The subjective
presence and intensity of DOMS were evaluated
using a visual analogue scale immediately after,
and 24 and 48h after each test. The mean plasma
concentration of PGE2 measured at rest and after
exercise was significantly lower in the group
treated with piroxicam (p < 0.05). However,
statistical analysis (two-way ANOVA test) revealed
that exercise did not cause any significant change
of mean plasma PGE2 over time in either of the
two groups. Eccentric work was followed by
severe muscle pain in extensor and flexor muscle
groups. Maximal soreness was noted 48h post-
exercise. Serum creatine kinase activity and the
serum concentration of myoglobin increased
significantly, and reached peak values 48h after
exercise in both experimental conditions (p <
0.001). By paired t-test, it appeared that there
were no significant differences in the serum
levels of these two markers of muscle damage
between the two groups at any time point. We
conclude that: (1) oral administration of pirox-
icam fails to reduce muscle damage and DOMS
caused by strenuous eccentric exercise; and (2)
the hypothetical role of increased PGE2 produc-
tion in eccentric exercise-induced muscle
damage, DOMS, and reduced isokinetic perfor-
mance is not substantiated by the present results.
Key words: Delayed onset muscle soreness, Eccentric
contraction, Isokinetic exercise, Muscle damage, Non-ster-
oidal anti-inflammatory agent, Prostaglandin
Piroxicam fails to reduce
myocellular enzyme leakage and
delayed onset muscle soreness
induced by isokinetic eccentric
exercise
J-L. Croisier, G. Caius,2"4"CA T. Monfils,1"4
G. Deby-Dupon,2"3 M. Fafchamps, I. Venneman,3
J-M. Crielaard, A. Juchms-Ferir,s
C. Lhermerout,
4 M. Lamy2"3 and C. Deby
2
1Department of Physical Medicine and
Rehabilitation, 2Center for the Biochemistry of
Oxygen, Institute of Chemistry, 3Department of
Anesthesiology and Intensive Care Medicine,
4Laboratory of Human Applied Physiology, ISEPK
and 5Department of Clinical Biology, CHU,
University of Liege, Sart Tilman, B-4000 Liege,
Belgium
CiCorresponding Author
Introduction
Delayed onset muscle soreness (DOMS) refers
to a dull, aching pain, frequently combined with
tenderness and stiffness, localized to groups of
previously active muscles. These symptoms are
usually observed following strenuous, unac-
customed exercise, especially when eccentric
contractions are involved.’2 DOMS sensations
develop in the first 24 h following muscular work
and subside within 5 to 7 days after exercise.
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Despite the volume of data that have accumulated
concerning DOMS during the last decade, the
underlying mechanisms of this phenomenon
remain poorly understood. Based on previous
studies showing that strenuous exercise causes
muscle and connective tissue damage, as well as
an inflammatory response involving the release of
algogenic inflammatory mediators such as pros-
taglandins (PG),4-7 it has been hypothesized that
increased PG production by activated macro-
phages in injured areas could be one of the main
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chemical stimuli responsible for DOMS.
8 Histolo-
gical and biochemical indices of exercise-induced
muscle damage,9-16 the presence of leucocytes
capable of producing arachidonic acid (AA)
derived products in damaged muscles,4’5’7 and
the increased production of these substances
during exercise
4-7 support this hypothesis. The
results of a recent human study, where ibuprofen,
a potent nonsteroidal anti-inflammatory drug
(NSAID), reduced both DOMS and the decrease
of muscle performance after strenuous eccentric
contractions
18 argued also for the involvement of
PGs. It should be pointed out, however, that the
effects of inhibitors of AA metabolism on DOMS
is a matter of controversy. Several research groups
have reported that anti-inflammatory agents inhib-
iting the production of AA-derived compounds
failed to alleviate soreness after exercise.’9’2
Among the possible factors responsible for these
discrepancies are the administration protocol of
NSAIDs and the effective doses that are
absorbed. Therefore, in an attempt to address the
question of whether metabolites of AA derived
from the cyclooxygenase pathway, especially
PGE2, are involved in DOMS, we studied the
effects of piroxicam (Feldene(R)), another potent
NSAID, on perceived soreness, biochemical
indices of muscle damage, and plasma levels of
PGE2 in subjects submitted to maximal eccentric
isokinetic contractions. To optimize the potential
effects of piroxicam on these variables, the drug
was administered both before (prophylactically)
and after (therapeutically) to each subject.
Methods
Subjects.. Ten moderately active, healthy male
subjects volunteered to take part in this study
after giving informed consent. Their mean age
(+ S.E.M.) and body mass were 22 4- 0.4 years
and 74 1.5 kg, respectively. None was cur-
rently involved in lower body resistance or
endurance training. They were requested to
refrain from strenuous exercise and to abstain
from the consumption of any form of medication
during the study period. The experimental proto-
col was approved by the Ethics Committee of the
University Hospital Center of Liege.
jects were familiarized with the experimental
procedures and possible risks involved. They
were accustomed to the isokinetic device by per-
forming 10 to 20 submaximal eccentric contrac-
tions of quadriceps and hamstring muscles. On
their second visit, the eccentric and concentric
maximum peak torque (PTmax) of the knee
flexor and extensor muscle groups were meas-
ured bilaterally as follows. Standard warm-up
exercises consisted of 5 min cycling at 75-100 W
on a bicycle ergometer (60 rpm) and stretching
of the muscle groups subsequendy used for iso-
kinetic contractions. This warm-up protocol was
systematically applied before each isokinetic trial.
After a 5 min recovery phase, the subjects per-
formed three maximal contractions of knee
flexor and extensor muscles at 60/s in the
eccentric mode. The greatest peak torque values
were taken to represent PTmax. At least 2 weeks
after this first test, the volunteers were randomly
divided into two groups of five subjects who
were given six capsules containing either 20 mg
of piroxicam or a placebo. Using a double-blind
procedure in which neither the subjects nor the
investigator providing the capsules were aware of
the subjects assigned group, the volunteers were
instructed to take one capsule per day, starting 3
days before the isokinetic sessions. Each subject
served as his own control, and completed two
study protocols separated by at least 6 weeks:
once with placebo and once with piroxicam.
Exercise consisted of eight stages of five maximal
contractions of the knee extensor and flexor
muscle groups of both legs, separated by 1 min
rest phases. To assess the effects of isokinetic
contractions on muscle function, PTmax was
measured on day two after exercise testing, using
the protocol described above.
Perception ofmuscle soreness and indirect evalu-
ation ofmuscle damage: The subjective presence
and intensity of DOMS were evaluated using a
visual analogue scale graded from 0 (no pain) to
10 (very severe, intolerable pain) immediately
after, and 24 and 48h after eccentric testing.
Increased serum levels of creatine kinase (CK)
and myoglobin (Mb) were used as indirect indices
of exercise-induced muscle damage.
Experimental procedures.. All isokinetic measure-
ments were performed on a Kin Trex device
(Meditronic Instruments SA, Ecublens, Switzer-
land) at 60/s angular velocity. During these
experiments, the subjects performed isokinetic
exercise in a seated position at approximately
105 of hip flexion. Belts placed across hips, chest
and thigh were used to stabilize their position.
On their first visit to the laboratory, the sub-
Blood sampling: Before each test, an indwelling
catheter was inserted into an antecubital vein and
sealed. Venous blood samples (10 ml) were col-
lected into sterile tubes immediately before iso-
kinetic test, 10 min after catheter insertion;
immediately after exercise, and after 30 min
recovery. Two additional blood samples were
taken by venipuncture 24 and 48 h after exercise,
respectively. The venous blood samples were
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divided in two aliquots: 5 ml whole fresh blood 400
into a plain plastic tube, and 5 ml of whole
blood into a vial containing EDTA as anti-
coagulant. The first portion was allowed to clot a00
at room temperature, and the serum phase was
used for the measurement of creatine kinase z (CK) activity and myoglobin (Mb) concentration.
The second portion was immediately centrifuged. =
200
The supernatants were kept at-70C until
plasma PGE2 assay.
Biochemical assays: Plasma PGE2 levels were
assessed using an enzyme immunoassay (Cayman
Chemical, Kit 514016). Routine spectrophoto-
metric techniques used in the Dept of Clinical
Biology were applied to measure serum CK
activity and Mb concentrations.
Pre-test Post-test Placebo Post-test Piroxicam
Quadriceps Hamstrings
Statistical analysis: Values in the text and figures
FIG. 1. Peak torque produced by quadriceps and hamstring are expressed as group means ___
S.E.M. For muscle groups in the eccentric mode before and 2 days after
each variable, differences between mean values maximal eccentric tests in the two experimental conditions.
---1 Placebo --
Piroxicam
0 30 min 24 48 h
Time
obtained at each time point in the two groups
were evaluated using a paired Student’s t-test. For
the variables listed above, a two-way analysis of
variance for repeated measures design (two-way
ANOVA test) was used to assess changes over
time. The level of statistical significance was set
to p < 0.05.
Results
Mean peak torque produced by the quadriceps
and hamstring muscle groups during pre- and
post-test exercise sessions in the two experi-
mental conditions are shown in Fig. 1. Pre-test
mean PTmax of knee flexor and extensor muscle
groups were 157 4- 9 and 339 ___
17 Nm, respec-
tively. Maximum eccentric contractions were not
followed by any significant change of this vari-
able after two days of recovery.
As shown in Fig. 2, eccentric exercise caused FIG. 2. Mean soreness rating score (arbitrary units) of the quad-
riceps and hamstring muscle groups before and after eccentric marked soreness, reaching peak levels 2 days exercise bouts in the two experimental conditions. 0: Pre-exer-
after isokinetic testing. The pattern of change of cise; 30 min: immediately after exercise; 24 h, 48 h: 24 h and
mean soreness scores over time, as well as mean 48 h after exercise.
soreness scores at each time point were not
significantly changed by piroxicam. The effects of
this agent on mean plasma PGE2 concentrations groups, reaching a maximum on day 2 of recov-
are illustrated in Fig. 3. When compared to the ery (p < 0.001). Serum Mb concentration also
placebo group, this variable was significantly demonstrated a delayed peak after 48 h recovery
decreased at four time points in the piroxicam in both experimental conditions (p < 0.001).
group (p < 0.05). By the two-way ANOVA test, it Piroxicam did not significantly change the mean
appeared that exercise did not cause any sig- serum levels of these biochemical markers of
nificant change of plasma PGE2 concentration muscle damage at any time point.
over time in either experimental condition.
The effects of exercise on serum levels of CK Discussion and Mb are shown in Fig. 4 and 5, respectively.
Beginning on the day after the isokinetic test, The marked increase of serum CK activity and
marked release of CK was observed in both Mb concentration following isokinetic eccentric
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FIG. 3. Plasma concentration of prostaglandin E2 as a function FIG. 5. Mean serum concentration of myoglobin (logarithmic
of time in the two experiments. Vertical bars are S.E.M. 0: Pre- scale) as a function of time in the placebo and piroxicam groups
exercise; 30 min: immediately after exercise; 60 min: after 30 (see Fig. 3).
min recovery; 24 h, 48 h: 24 h and 48 h after exercise.
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available concerning DOMS, litde is known about
its underlying mechanisms. Based on literature
data showing that eccentric muscular work is the
most effective way to cause muscle damage asso-
ciated with humoral and cellular indices of an
inflammatory response, it has been suggested
that algogenic substances derived from arachi-
donic acid metabolism, especially PGE2, could
play a pivotal role in the production of the
delayed sensation of pain,
8 a cardinal symptom
of DOMS. The increase of muscle AA levels
accompanying static contraction,
22 the produc-
tion of prostaglandins during strenuous muscular
work,4- as well as reports of the beneficial
0 30 60 min 24 48 h effects of NSAIDs on exercise-induced injuries in
Time mouse skeletal muscle fibres2 and certain maN-
FIG. 4. Mean serum activity of creatine kinase (logarithmic scale) festations of DOMS in man,18’21’24 lend support
as a function of time in the placebo and piroxicam groups (see tO this hypothesis. However, previous studies
Fig. 3). suggesting that other factors could also be
involved in exercise-induced pain, as well as the
exercise is in agreement with the results of pre- discrepancies concerning the effects of drugs
vious studies. 1’3’1’15’18’21 This protein leakage known to inhibit the AA metabolism on DOMS
from skeletal muscle has been widely used to led us to verify whether piroxicam could effec-
estimate the severity of exercise-induced skeletal tively help to manage pain, reduced muscle per-
muscle damage. In accordance with this view, the formance and muscle damage following maximal
data presented in Figs 4 and 5 indicate that the isokinetic contractions in the eccentric mode. To
present exercise protocol caused severe myo- optimize the inhibitory action of this agent on
cellular injury. Surprisingly, when compared to PGE2 synthesis, six doses of 20 mg piroxicams
the PTmax measured before isokinetic exercise, daily, with initial dose given 3 days before the
the ability of the knee flexor and extensor exercise tests were administered. The significant
muscle groups to produce force was unaffected reduction of plasma PGE2 concentrations
2 days after the damage induced by the two demonstrates the efficacy of cyclooxygenase
experimental conditions. This suggests that blockade. However, piroxicam administered had
muscle injury was not severe enough to .alter no effect on muscle enzyme leakage and DOMS
PTmax and/or that motor units containing non- following isokinetic eccentric contractions. These
damage fibres were recruited, findings lead us to conclude that PGE2 (and
Despite the large number of studies currently probably other compounds) derived from AA
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metabolism via the cyclooxygenase pathway do
not play a major role in the pathogenesis of
DOMS nor in exercise-induced damage. Never-
theless, the hypothesis that larger doses of pirox-
icam or lowering the plasma levels of PGE2
below 200 pg/ml could reduce DOMS in subjects
submitted to damaging exercise of longer dura-
tion deserves to be tested experimentally.
In contrast with previous studies where stren-
uous exercise was found to increase plasma and
muscle levels of AA-derived prodcuts,4-7 there
was no significant change in plasma PGE2 con-
centration over time in the two experimental
conditions. The reasons for this discrepancy are
unclear. One possibility is that we measured
plasma levels of PGE2 in venous blood samples
drawn at a site distant from the active muscles in
which this compound has been shown to accu-
mulate.7 Because of the short half-life of PGE2 in
blood, it is possible that regional changes of this
variable in the venous effluent of skeletal
muscles are not detectable in blood from a
forearm vein. Another factor that could act in
concert with the sampling site effects is the
limited muscle mass involved in the isokinetic
exercise. The isokinetic device used in the
present study does not allow simultaneous con-
traction of limb muscles on both sides. It is
therefore possible that the amount of PGE2
released from the active muscles was too low to
be reflected by changes in venous PGE2 con-
centrations measured in blood samples drawn
from a forearm vein. For ethical and technical
reasons, we did not measure the arterio-venous
difference of PGE2 at the lower limbs. Therefore,
increased production of this compound induced
by exercise in the active muscles cannot be deft-
nitively ruled out. Nevertheless, the significant
difference of resting and post-exercise plasma
concentrations of PGE2 between the two groups
demonstrates that the dose of piroxicam used in
this study effectively inhibited the production of
this compound. As mentioned above, because
the failure to find a significant difference in
either the serum levels of the biochemical
markers of muscle injury or in the intensity of
DOMS between the two groups, despite pirox-
icam-induced reduction of plasma PGE2 con-
centrations, argues against the hypothesis that
cyclooxygenase-derived AA metabolism are
involved in exercise-induced damage and DOMS.
Based on these results, it would appear that the
activation of pain afferents after eccentric con-
tractions is caused by other noxious stimuli. It
has been suggested that increased intramuscular
pressure,
2 and/or production of algogenic sub-
stances such as serotonin, histamine, acetylcho-
line and kinins could be involved in the
production of DOMS. To our knowledge, these
hypotheses remain to be tested experimentally.
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